» Authors » Xiangyang Bu

Xiangyang Bu

Explore the profile of Xiangyang Bu including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 5
Citations 42
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Bu X, Ding W, Guo S, Wang Y, Feng J, Wang P, et al.
Ann Transl Med . 2023 Feb; 11(1):22. PMID: 36760242
Background: Bile duct obstruction-induced liver fibrosis is mainly caused by cholestatic liver injury which stimulates liver cell inflammation and damages the liver structure, causing liver fibrosis. The differentially expressed microRNAs...
2.
Wang Y, Chen B, Xiao C, Yu J, Bu X, Jiang F, et al.
Front Physiol . 2021 Dec; 12:737313. PMID: 34867446
Liver fibrosis is a common pathological feature of end-stage liver disease and has no effective treatment. MicroRNAs (miRNAs) have been found to modulate gene expression in liver disease. But the...
3.
Bu X, Ge Z, Ma J, Guo S, Wang Y, Liu J
J BUON . 2015 May; 20(2):548-54. PMID: 26011348
Purpose: To compare the clinical efficacy of surgical resection (SR) and radiofrequency ablation (RFA) for the treatment of small hepatocellular carcinoma (SHC; ≥ 5 cm in diameter). Methods: The clinical...
4.
Ge Z, Zhang B, Bu X, Wang Y, Xiang L, Tan J
Tumour Biol . 2014 Sep; 35(12):12441-7. PMID: 25195135
The molecular regulation of growth of hepatocellular carcinoma (HCC) is yet to be fully clarified. Here we found a significantly higher ratio of phosphorylated β-catenin (phos-β-cat) to β-catenin (β-cat) as...
5.
Dong J, Yang S, Zeng J, Cai S, Ji W, Duan W, et al.
Semin Liver Dis . 2013 Aug; 33(3):189-203. PMID: 23943100
Continuous theoretical and technological progress in the face of increasing expectations for quality health care has transformed the surgical paradigm. The authors systematically review these historical trends and propose the...